HRT Financial’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-28,451
| Closed | -$785K | – | 2665 |
|
2024
Q3 | $785K | Buy |
+28,451
| New | +$785K | ﹤0.01% | 1264 |
|
2024
Q1 | – | Sell |
-24,835
| Closed | -$963K | – | 2605 |
|
2023
Q4 | $963K | Buy |
+24,835
| New | +$963K | 0.01% | 931 |
|
2022
Q1 | – | Sell |
-11,122
| Closed | -$1.72M | – | 3230 |
|
2021
Q4 | $1.72M | Buy |
+11,122
| New | +$1.72M | 0.01% | 655 |
|